Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (161-170 of 770) with videos related to

Pageof 77
Sort By:
JAMA|December 22, 2018
Providing Individual Research Results to Participants-ReplyCharlene A Wong, Adrian F Hernandez, Robert M Califf
Journal of the American College of Cardiology|December 12, 2024
Giving Cardiovascular Clinicians a Voice in Evidence Generation: A Collaboration Between the FDA and JACCHaider J Warraich, Harlan M Krumholz, Robert M Califf
JAMA|March 16, 2016
Biomarkers and Surrogate Endpoints: Developing Common Terminology and DefinitionsMelissa A Robb, Pamela M McInnes, Robert M Califf
Journal of the American College of Cardiology|February 8, 2020
New Approaches to Conducting Randomized Controlled TrialsAlexander C Fanaroff, Robert M Califf, Renato D Lopes
The New England Journal of Medicine|December 14, 2016
Clarifying Stem-Cell Therapy's Benefits and RisksPeter W Marks, Celia M Witten, Robert M Califf
JAMA|June 23, 2018
Return of Research Results to Study Participants: Uncharted and UntestedCharlene A Wong, Adrian F Hernandez, Robert M Califf
Science (New York, N.Y.)|April 9, 2026
Diagnostics investments and disease burdenKathryn A Phillips, Danea M Horn, Robert M Califf
The New England Journal of Medicine|August 14, 2009
Premature release of data from clinical trials of ezetimibeRobert M Califf, Robert A Harrington, Michael A Blazing
The American Journal of Medicine|May 1, 2007
Performance measures have a major effect on cardiovascular outcomes: a reviewRajendra H Mehta, Eric D Peterson, Robert M Califf
JAMA|June 3, 2024
Why Should the FDA Focus on Pragmatic Clinical Research?Ali B Abbasi, Lesley H Curtis, Robert M Califf
Pageof 77

Showing results (161-170 of 770) with videos related to

Sort By:
Pageof 77
JAMA|December 22, 2018
Providing Individual Research Results to Participants-ReplyCharlene A Wong, Adrian F Hernandez, Robert M Califf
Journal of the American College of Cardiology|December 12, 2024
Giving Cardiovascular Clinicians a Voice in Evidence Generation: A Collaboration Between the FDA and JACCHaider J Warraich, Harlan M Krumholz, Robert M Califf
JAMA|March 16, 2016
Biomarkers and Surrogate Endpoints: Developing Common Terminology and DefinitionsMelissa A Robb, Pamela M McInnes, Robert M Califf
Journal of the American College of Cardiology|February 8, 2020
New Approaches to Conducting Randomized Controlled TrialsAlexander C Fanaroff, Robert M Califf, Renato D Lopes
The New England Journal of Medicine|December 14, 2016
Clarifying Stem-Cell Therapy's Benefits and RisksPeter W Marks, Celia M Witten, Robert M Califf
JAMA|June 23, 2018
Return of Research Results to Study Participants: Uncharted and UntestedCharlene A Wong, Adrian F Hernandez, Robert M Califf
Science (New York, N.Y.)|April 9, 2026
Diagnostics investments and disease burdenKathryn A Phillips, Danea M Horn, Robert M Califf
The New England Journal of Medicine|August 14, 2009
Premature release of data from clinical trials of ezetimibeRobert M Califf, Robert A Harrington, Michael A Blazing
The American Journal of Medicine|May 1, 2007
Performance measures have a major effect on cardiovascular outcomes: a reviewRajendra H Mehta, Eric D Peterson, Robert M Califf
JAMA|June 3, 2024
Why Should the FDA Focus on Pragmatic Clinical Research?Ali B Abbasi, Lesley H Curtis, Robert M Califf
Pageof 77